MDLs are complicated. MDLs are chaotic, messy, and ugly unless they have structure and order. Bringing ..
Congress authorized multidistrict litigation “for the convenience of parties and witnesses” and to “promote ..
You can waive remand. That’s Lexecon, Inc. v. Milberg Weiss Bershad Hynes & Lerach, 523 U.S. ..
Late last month Bexis attended the annual ACI Drug and Medical Device Conference in New York. In between ..
J.P.M.L. Denies Request for New Gadolinium MDL “Eventually, all things merge into one, and a river ..
It’s been a long road. Well after product liability litigation over Accutane and inflammatory bowel ..
We had occasion not long ago to reread closely Lexecon v. Milberg Weiss Bershad Hynes & Lerach, ..
So you’re sitting next to one of your client’s senior executives. You’re at a large table in a larger ..
Over 11 years ago the blog published a post called “Anatomy of a Mass Tort,” which endeavored to explain ..
It has been said, with maybe a bit of sarcasm, that a company developing a drug hopes that its drug will ..
Sure, it was enjoyable to read In re DePuy Orthopaedics, Inc., Pinnacle Hip Implant Product Liability ..
On Wednesday, the Fifth Circuit was finally able speak to what’s been going on in a Dallas courtroom ..
We wrote a post not too long ago recommending that MDL defendants seriously consider limiting so called ..